Oxford BioDynamics PLC OBD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX0.12
- Day Range
- GBX0.11–0.12
- 52-Week Range
- GBX0.08–0.75
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 13.44B
- Market Cap
- GBX1.52B
- Volume/Avg
- 91M / 28M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 37
Valuation
|
Metric
|
OBD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.76 |
Price/Cash Flow | — |
Price/Earnings
OBD
Financial Strength
|
Metric
|
OBD
|
|---|---|
Quick Ratio | 1.89 |
Current Ratio | 2.01 |
Interest Coverage | −56.13 |
Quick Ratio
OBD
Profitability
|
Metric
|
OBD
|
|---|---|
Return on Assets (Normalized) | −85.36% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −103.39% |
Return on Assets
OBD
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#V?m%SS | LOCK|lp | $241B | |||
| Danaher Corp
DHR
| LOCK|$T#@$#c | LOCK|qfb | $149B | |||
| Agilent Technologies Inc
A
| LOCK|j@!?>K!> | LOCK|z% | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|&Tg#yr? | LOCK|<@D#& | $43B | |||
| Waters Corp
WAT
| LOCK|fBQWg? | LOCK|bM | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|S#g!Sfn# | LOCK|WbG | $41B | |||
| Illumina Inc
ILMN
| LOCK|Lwr!$^z | LOCK|h<%^f | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|!d@<&Lc | LOCK|>^KH | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Rwnn%g | LOCK|g#rQG | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|Xp#!#%<X | LOCK|CdY%& | $25B |
United States